Zepbound Vials vs Pen Administration and Storage
Medically reviewed by Medical Advisory Board Last reviewed 2026-09-11
Both delivery formats provide the identical active medication across all six strengths, but vials require manual syringe preparation and follow separate room-temperature storage timelines.
Zepbound (tirzepatide) ships in three federally approved formats: a single-dose prefilled pen, a single-dose vial, and a multi-dose vial. All three options deliver identical medication across the same six dose strengths, with no difference in clinical potency between containers. Vials require patients to supply a separate syringe and needle, whereas the prefilled pen functions as a self-contained autoinjector. Room-temperature stability also diverges outside the refrigerator, allowing 21 days for single-dose products compared to 30 days across four doses for multi-dose vials.
Zepbound vials and prefilled pens contain the identical active medication across all six dose strengths. At The Metabolic Journal, we break down metabolic drug delivery systems to help patients understand their prescription options before speaking with their clinical team. What differs is how you prepare the injection, the equipment you need, and how long each format lasts at room temperature.
According to the Food and Drug Administration (FDA) prescribing information, Zepbound (tirzepatide) is approved for chronic weight management in adults with obesity or overweight accompanied by weight-related medical conditions. Manufacturer Eli Lilly supplies Zepbound in single-dose pens, single-dose vials, and multi-dose vials. Choosing between these formats depends on insurance formulary coverage, personal dexterity, and your dispensing pharmacy's available inventory.
Partner · Opt Health
Want medical weight loss instead of another diet?
Opt Health prescribes and monitors GLP-1 therapy against real labs — insulin, A1C, lipids, thyroid, hormones — so the plan fits your physiology rather than a generic protocol. Medication ships to your door.
See Opt Health's weight-loss program →Three Distinct Zepbound Formats and Available Strengths
Zepbound is supplied in three distinct physical formats: a single-dose prefilled pen, a single-dose vial, and a multi-dose vial. A common misconception among patients is that vials exist only for lower starter doses. According to the FDA-approved prescribing information, the single-dose pen and single-dose vial are both manufactured in all six standard dose strengths.
- 2.5 mg/0.5 mL
- 5 mg/0.5 mL
- 7.5 mg/0.5 mL
- 10 mg/0.5 mL
- 12.5 mg/0.5 mL
- 15 mg/0.5 mL
Patients stepping up to higher weekly doses do not need to switch back to an autoinjector pen simply to access maintenance quantities. The single-dose vial delivers the exact same volume of liquid (0.5 mL) as the single-dose pen across every tier of titration.
The multi-dose vial provides an alternative container format by delivering four full doses from a single glass vial. The multi-dose vial is supplied at six equivalent strengths:
- 10 mg/2.4 mL (4.17 mg/mL) for four 2.5 mg/0.6 mL doses
- 20 mg/2.4 mL (8.33 mg/mL) for four 5 mg/0.6 mL doses
- 30 mg/2.4 mL (12.5 mg/mL) for four 7.5 mg/0.6 mL doses
- 40 mg/2.4 mL (16.7 mg/mL) for four 10 mg/0.6 mL doses
- 50 mg/2.4 mL (20.8 mg/mL) for four 12.5 mg/0.6 mL doses
- 60 mg/2.4 mL (25 mg/mL) for four 15 mg/0.6 mL doses
Each multi-dose injection draws 0.6 mL of fluid per dose rather than the 0.5 mL volume used in single-dose options.
Administration Differences Between Vials and Prefilled Pens
The main operational difference between Zepbound formats is that prefilled pens automate injection delivery, while vials require manual syringe draw-up. The single-dose pen functions as an integrated autoinjector. You unlock the pen base, place the clear end flat against your skin, and press the injection button. An internal spring pushes the hidden needle into the tissue, delivers the pre-measured 0.5 mL dose, and retracts automatically.
Vials require you or a caregiver to measure and extract each dose manually. The FDA label instructs patients to use a syringe appropriate for dose administration, such as a 1 mL syringe capable of measuring a 0.5 mL or 0.6 mL dose. Patients must always use a new, sterile syringe and needle for every single injection. Because single-dose and multi-dose vial cartons do not package these tools by default, check with your pharmacy about what supplies come with your prescription.
Both formats are administered subcutaneously once every seven days at any time of day, with or without meals. Acceptable injection sites include the abdomen, the front of the thighs, and the back of the upper arm when assisted by another person. Patients must rotate their injection site each week to minimize tissue irritation and avoid injecting into bruised or tender skin.
Dose Packaging and Supply Counts Across Formats
Zepbound packaging configurations determine how many weeks of medication you receive in each pharmacy carton. Single-dose pens ship in cartons of four autoinjectors, which equals a standard four-week supply. Each pen contains a single dose and is discarded into an approved sharps container immediately after injection.
Single-dose vials are distributed in either a one-pack or a four-pack carton. Each single-dose vial holds one individual dose of medication. Even if residual fluid remains in the vial after drawing up your weekly dose, the FDA prescribing information states that you must discard the single-dose vial immediately after use.
The multi-dose vial packages four weekly doses into a single glass container, providing four weeks of therapy. Patients withdraw one dose each week using a fresh needle and syringe. After four weekly doses have been removed, or after 30 days have passed since first use, the remaining container must be discarded.
Comparison of Zepbound Delivery Formats
The table below lines up all three formats side by side. Use it to see which configuration fits your living situation and injection confidence.
| Feature | Single-Dose Pen | Single-Dose Vial | Multi-Dose Vial |
|---|---|---|---|
| Injection Hardware | Built-in hidden needle and automated spring | Requires separate syringe and needle | Requires separate syringe and needle for each dose |
| Doses Per Container | 1 dose per pen (carton of 4) | 1 dose per vial (1-pack or 4-pack) | 4 doses per single vial |
| Volume Per Dose | 0.5 mL | 0.5 mL | 0.6 mL |
| Room-Temperature Limit | Up to 21 days below 30°C (86°F) | Up to 21 days below 30°C (86°F) | Up to 30 days before opening; discard 30 days after first use |
| Strengths Available | All 6 strengths (2.5 mg to 15 mg) | All 6 strengths (2.5 mg to 15 mg) | All 6 equivalent strengths (2.5 mg to 15 mg weekly) |
| Practical Verdict | Best for automated, one-step injections | Best for patients comfortable with manual syringes | Best for compact storage and multi-dose convenience |
The prefilled pen eliminates the need to measure liquid, which benefits individuals nervous about needle handling. In contrast, vials reduce packaging volume and allow patients to draw up their medication manually using standard diabetic syringes.
Storage Guidelines and Room-Temperature Expiration Timelines
Single-dose and multi-dose Zepbound presentations follow distinct room-temperature stability rules that dictate when unchilled medication must be discarded. Both the single-dose pen and the single-dose vial must be stored in a refrigerator between 2°C and 8°C (36°F to 46°F) in their original carton to protect the liquid from light.
Refrigeration is not always available. In that case, single-dose pens and single-dose vials can be kept unrefrigerated at up to 30°C (86°F) for up to 21 days. Once one reaches room temperature, though, it must never go back in the fridge. If you do not inject the dose within 21 days of removing it from refrigeration, you must safely discard it. Never freeze Zepbound. Discard it immediately if it has been frozen.
The multi-dose vial follows a separate set of storage instructions. An unopened multi-dose vial can remain refrigerated between 2°C and 8°C (36°F to 46°F) until the printed expiration date, or kept at room temperature up to 30°C (86°F) for up to 30 days before opening. Once opened, the multi-dose vial must be discarded after 30 days at room temperature, 30 days after the first injection, or after four weekly doses have been administered, whichever arrives first.
Side Effect Profiles and Dose Tolerability
The active drug is identical across pens and vials. Physical format does not change Zepbound's side-effect profile. In clinical trials, the most common adverse reactions, reported in 5% or more of participants, were:
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Abdominal pain
- Dyspepsia
- Injection site reactions
- Fatigue
- Hypersensitivity reactions
- Eructation
- Hair loss
- Gastroesophageal reflux disease
Gastrointestinal side effects occur at similar rates regardless of whether the solution was injected from an autoinjector or a manual syringe. Clinical trial data shows that severe gastrointestinal events increased with higher doses: 1.7% in the 5 mg group, 2.5% in the 10 mg group, and 3.1% in the 15 mg group, compared to 1.0% in the placebo cohort.
For symptom management techniques and onset timelines, read our comprehensive overview of Zepbound side effects. You can also consult our breakdown of the Zepbound dosing schedule to understand how standard monthly titration helps your digestive system adapt. If you are comparing tirzepatide against other metabolic options, explore our direct guide on Zepbound vs Ozempic or our analysis of top Zepbound alternatives.
Prescription Access and Candidate Considerations
Access to Zepbound vials or pens depends primarily on insurance coverage guidelines, commercial availability, and personal injection capability. Commercial health plans often specify preferred delivery formats on their drug formularies. Some insurers restrict coverage to prefilled pens, while others mandate specific prior authorization criteria for vials. To review payer policies in detail, visit our breakdowns of Kaiser Zepbound coverage, Humana Zepbound coverage, and Florida Blue Zepbound coverage.
Patients who pay out of pocket frequently explore vials through direct cash-pay programs. Manufacturer self-pay pricing structures change over time, so patients should check current self-pay program terms directly on the Eli Lilly self-pay site or confirm pricing with their dispensing pharmacy.
Manual vials are not suitable for everyone. Individuals with severe tremors, reduced hand strength, significant vision loss, or a severe phobia of manual needles should avoid vial administration. For these patients, prefilled autoinjectors provide a safer mechanism that conceals the needle throughout injection.
Our assessment would change if health insurers broadly removed pens from preferred tiers or if pharmacies stopped stocking manual injection supplies. Until such shifts happen, both delivery formats remain clinically viable choices. Before selecting a treatment format, discuss Zepbound vials vs pen options with your prescribing clinician and pharmacist to verify which configuration aligns with your insurance coverage and daily injection preferences.
What to Look For in a Body-Composition Scale
A bioimpedance scale trends body fat and muscle rather than just weight — useful when the number stalls but your composition is improving. The absolute body-fat % isn't lab-accurate, so use it for TRENDS at a consistent time of day. Choose one that syncs to an app so you can watch the trend line.


Frequently Asked Questions
What is the difference between a Zepbound vial and a Zepbound pen?
A Zepbound pen is a prefilled single-dose autoinjector with an integrated needle that delivers medication with the push of a button. A Zepbound vial contains liquid tirzepatide that you or a caregiver must manually withdraw using a separate needle and syringe before subcutaneous injection.
Do Zepbound vials come in the same doses as the pen?
Yes, single-dose Zepbound vials come in the exact same six dose strengths as prefilled pens: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Multi-dose vials also provide equivalent weekly doses across all six therapeutic strengths.
How many doses are in a Zepbound vial?
A single-dose Zepbound vial contains one weekly dose and must be discarded immediately after use, even if extra liquid remains. A multi-dose Zepbound vial contains four weekly doses, supplying four weeks of treatment from a single container.
Do you need a prescription for a specific Zepbound format, or can you choose?
Your prescription must specify whether your pharmacy dispenses prefilled pens or vials. Your insurer's formulary rules, cash-pay eligibility, and local pharmacy inventory will determine whether you can receive your preferred format.
How long can a Zepbound vial be stored at room temperature?
A single-dose Zepbound vial can be kept at room temperature up to 30°C (86°F) for up to 21 days, after which it must be discarded and cannot return to the refrigerator. An unopened multi-dose vial can stay at room temperature for up to 30 days before opening, and once opened, it must be discarded after 30 days.
Topic updates
Get the weekly metabolic health roundup
Insulin resistance, blood sugar, visceral fat, GLP-1 plateaus, metabolic syndrome, and weight-loss physiology.
Want weight loss handled by a physician who works from your labs? See how Opt Health does it →
Check Where You Stand
Take our free health assessment to understand your metabolic, hormonal, and recovery risk factors — and get personalized recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results
Related Guides
-
Zepbound Side Effects
Zepbound side effects: dosing/titration, GI effects, injection-site care, duration/onset timing, and rare serious risks.
-
Does Humana Cover Zepbound
Does Humana cover Zepbound? Medicare Advantage, Part D, the GLP-1 Bridge program, and commercial plans, by pathway.
-
Zepbound Dosing Schedule
Zepbound dosing schedule: the FDA titration steps and SURMOUNT trial dose-response data, without ranking a 'best' dose.
See more related guides
-
Does Florida Blue Cover Zepbound? Prime Therapeutics Prior Authorization and the BMI Threshold Explained
Does Florida Blue cover Zepbound? Prime Therapeutics prior authorization, the BMI threshold, and why Mounjaro doesn't qualify.
-
Can You Take Metformin and Zepbound Together? What the Overlap Means for Side Effects
Metformin and Zepbound together: why prescribers combine them, the overlapping GI side effects, and what changes when you do.
-
Does Kaiser Cover Zepbound? Kaiser's Own Published Clinical Criteria and Step-therapy Ladder, Explained
Does Kaiser cover Zepbound? Kaiser Northwest's published BMI, comorbidity, and step-therapy criteria for tirzepatide, region by region.
-
Foundayo vs Zepbound: New Oral GLP-1 Pill vs the Strongest Weekly Injection Compared
Foundayo vs Zepbound: new daily GLP-1 pill vs the strongest weekly dual-mechanism injection.
-
Saxenda vs Zepbound: Daily Liraglutide vs Weekly Dual-action Tirzepatide Compared
Saxenda vs Zepbound: daily liraglutide vs weekly dual-action tirzepatide — trial results compared.
Affiliate disclosure: The Metabolic Journal is reader-supported. Some links above are affiliate or referral links and we may earn a commission at no extra cost to you. As an Amazon Associate we earn from qualifying purchases. Products are chosen on the merits; commissions never influence what we recommend. This is general information, not medical advice — talk to your clinician before acting.